Moving Medicine Forward

CTI Clinical Trial and Consulting Services presents Moving Medicine Forward, a podcast centered on advancements in healthcare and elevating individual’s stories and expertise. CTI, a global Contract Research organization with associates in 60 countries, has contributed to 10,000+ projects, 200+ drug and device approvals, and 300+ pharmaceutical and emerging biotechnology partners. Our group of innovative thinkers work to change the lives of chronically and critically ill patients.

Moving Medicine Forward is a science podcast hosted by CTI Clinical Trials, with 75 episodes on record and a Required Pod Score of 80.

CTI Clinical Trials hosts Moving Medicine Forward, a science show with 75 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #76

  The Future is Cellular: Optieum Bio’s Next-Generation Approach to Glioblastoma

  Oct 1, 202618 minS1

  Glioblastoma remains one of the most aggressive and difficult-to-treat forms of brain cancer, with recurrence posing a significant challenge for patients and researchers alike. In this episode of Moving Medicine Forward , Jeremy Schrand sits down with Moya Daniels, Vice President, Head of Regulatory and QA at Optieum Biotechnologies, to discuss the company's novel CAR-T cell therapy program, OPTF01, and its potential to transform treatment for recurrent glioblastoma. Moya shares insights into the science behind targeting both tumor cells and the tumor microenvironment, the evolving landscape of cell and gene therapy, and how global collaboration is helping accelerate innovation for patients with serious diseases. 1:30 | Introducing Optieum and the science behind OPTF01 2:20 | The unmet need in glioblastoma and the challenge of recurrence 4:45 | How OPF-001 differs from other treatment approaches 6:00 | Japan's role in advancing cell and gene therapy innovation 7:20 | Global regulatory strategy and the future of regenerative medicine 8:30 | Lessons from the Asia-Pacific biotech landscape 10:30 | The importance of collaboration in early clinical development 13:00 | What successful biotech-CRO partnerships look like 16:00 | Upcoming milestones for Optieum and the future of CAR-T therapies 17:15 | Expanding cell therapy beyond oncology into broader disease areas

  ListenShow Notes
• 

  Episode #75

  One Mission, Many Journeys: Celebrating 27 Years of CTI

  Sep 24, 202618 min

  As CTI celebrates 27 years of moving medicine forward, Hadley Decker, Senior Director, Global Training and Development, and Natiq Fazlani, Research Associate, share their unique career journeys at CTI. Through the lens of two employees at very different stages of their careers, they discuss professional growth, the value of curiosity, and the culture that continues to shape CTI's mission of advancing clinical research and improving patients' lives. For more on the Research Associate Program listen to this previous episode or click here 1:13 Hadley Decker shares her 25-year CTI journey, from clinical research associate to senior director of global training and development, and how each role shaped her career. 2:04 Hadley reflects on what drew her to CTI, including the opportunity to work on meaningful research and contribute to studies that advance patient care. 4:43 Natiq Fazlani discusses joining CTI and how the company's culture and people made it an appealing place to start his career. 6:26 Hadley explains how taking on new roles and learning through complex studies accelerated her professional growth. 7:22 Natiq shares how embracing new opportunities and staying curious helped him build knowledge and confidence early in his CTI career. 8:40 The group discusses how working with colleagues around the world broadens perspectives and strengthens collaboration across CTI. 10:17 Hadley reflects on CTI's growth over 27 years and explains why the company's commitment to patients remains unchanged. 11:15 Natiq describes how CTI's culture shows up in daily interactions through collaboration, support, and shared goals. 12:08 Hadley highlights studies that led to approved therapies and shares why those experiences reinforced the impact of clinical research. 14:28 Hadley discusses the qualities she sees in newer employees that give her confidence in CTI's future. 14:40 Natiq shares what excites him most about his future at CTI, including the support and encouragement he has received since joining the company. 15:11 Both guests offer advice for employees starting at CTI, emphasizing curiosity, initiative, and understanding the purpose behind the work they do.

  ListenShow Notes
• 

  Episode #74

  More Time, More Options, More Hope: The Alzheimer's Association's Roadmap for Early Screening

  Sep 17, 202634 minS1

  Alzheimer's disease affects millions of individuals and families, yet many people remain unaware of the critical role early detection can play in improving outcomes. In this episode, host Jeremy Schrand is joined by Andrew Pytlik and Patti Hahn of the Alzheimer's Association to discuss the growing importance of cognitive screening, advances in diagnostic testing, and the steps individuals can take today to support long-term brain health. Together, they explore the realities facing patients, caregivers, and healthcare providers, while sharing why earlier recognition, stronger community support, and continued research are creating new hope for the future of Alzheimer's care. 1:00 | Meet the Alzheimer's Association and its mission to support patients, families, and research. 3:56 | Why Alzheimer's often develops years before symptoms appear and why early detection matters. 6:47 | Brain health habits that may help reduce risk, including sleep, exercise, and lifestyle choices. 8:42 | Common misconceptions about Alzheimer's and warning signs that go beyond memory loss. 11:27 | New advances in screening, blood-based biomarker testing, and earlier diagnosis. 14:59 | The impact of Alzheimer's on caregivers, families, and the workplace. 17:51 | Inside the Walk to End Alzheimer's and how community engagement accelerates research and support. 23:11 | Volunteer, advocacy, and fundraising opportunities that help advance the mission year-round. 27:01 | How employer partnerships, including CTI Cares, can strengthen awareness and community impact. 29:13 | Looking ahead: the future of Alzheimer's screening, treatment, and hope for patients and families.

  ListenShow Notes
• 

  Episode #72

  Funding the Future: Closing Critical Gaps in Childhood Cancer Research

  Sep 10, 202623 minS1

  Childhood cancer research faces unique challenges, from limited funding opportunities to fewer treatment options compared to adult cancers. In this episode of Moving Medicine Forward , host Jeremy Schrand is joined by Jill Brink, Executive Director of CancerFree KIDS, Dr. Meisam Nami of Cincinnati Children's, and Dr. Ezgi Elmas of CARTx Therapeutics to discuss how early-stage funding is helping researchers pursue bold ideas that could transform pediatric cancer care. Together, they explore the critical role nonprofit organizations play in advancing innovation, the promise of next-generation cell therapies, and how collaboration across research, healthcare, and industry is helping bring new treatment options closer to the children and families who need them most. 00:00 | Introduction to CancerFree KIDS and pediatric cancer research 01:37 | Why childhood cancer research needs bold, early-stage funding 04:01 | Bridging the gap between scientific discovery and patient care 06:18 | How nonprofit funding helped launch a breakthrough cell therapy innovation 07:06 | Understanding gene-edited and off-the-shelf cancer therapies 10:28 | Closing critical gaps in pediatric cancer research and treatment development 14:54 | The power of collaboration across nonprofits, healthcare, and biotech 18:29 | What gives researchers hope for the future of pediatric cancer care

  ListenShow Notes
• 

  Episode #71

  MMF Rewind | Building Better Clinical Trials: Study Start-Up, Patients, and Global Data

  Sep 2, 202623 min

  This week, we're revisiting a previous conversation with Megan Kamm, Senior Vice President of Client Delivery, and Josh Schroeder, Vice President of Site & Field Operations, to discuss how strong planning, site partnerships, and cross-functional collaboration drive successful trial execution. From feasibility and study startup to patient-centered decision-making, biometrics strategy, and global expansion, they share insights into the operational challenges—and opportunities—behind bringing innovative therapies to patients faster. 01:18 Megan Kamm and Josh Schroeder discuss how their expanded leadership roles have created new opportunities to collaborate across functions and support trial delivery. 03:12 The conversation explores the early decisions that shape trial success, from feasibility planning to selecting the right sites and regions. 04:22 Megan explains how site engagement and thoughtful study design help reduce burden and support successful trial execution. 05:28 Josh and Megan share how project teams, CRAs, and other functions work together to keep studies running smoothly. 06:15 The discussion highlights common challenges during study startup and how proactive planning can reduce delays and enrollment risks. 10:23 Josh and Megan provide examples of how strong collaboration helped accelerate enrollment and deliver data more efficiently. 12:32 Megan discusses how biometrics teams contribute from protocol development through data analysis, helping guide study strategy. 13:32 Josh explains how endpoint priorities and statistical planning influence monitoring strategies throughout a trial. 14:43 The conversation turns to leadership, focusing on training, alignment, and consistent decision-making across global teams. 16:02 Megan and Josh reflect on what sets CTI apart, highlighting a culture centered on patients and collaboration. 18:26 The discussion looks at the future of clinical research, including advances in technology, AI, and trial operations. 20:32 Josh shares insights into CTI’s growth in China and the operational considerations that come with expanding into the region.

  ListenShow Notes

Recent guests on Moving Medicine Forward. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.